These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25337860)

  • 1. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.
    Jeličić Kadić A; Žanić M; Škaričić N; Marušić A
    PLoS One; 2014; 9(10):e111474. PubMed ID: 25337860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of evidence supporting the Federation of Bosnia and Herzegovina reimbursement medicines lists: role of the WHO Essential Medicines List, Cochrane systematic reviews and technology assessment reports.
    Mahmić-Kaknjo M; Marušić A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):825-33. PubMed ID: 25956715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access and use of WHO essential medicines in Italy.
    Petrella A; Fortinguerra F; Cangini A; Pierantozzi A; Trotta F
    Front Public Health; 2023; 11():1211208. PubMed ID: 37881343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
    Baxi SM; Beall R; Yang J; Mackey TK
    Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
    Chivukula MV; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interpretation of China national essential medicines list 2018.
    Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
    [No Abstract]   [Full Text] [Related]  

  • 7. A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.
    Slamang W; Scott C; Foster HE
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):63. PubMed ID: 38965620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders.
    Papola D; Ostuzzi G; Todesco B; Gastaldon C; Hanna F; Chatterjee S; van Ommeren M; Barbui C
    Lancet Psychiatry; 2023 Oct; 10(10):809-816. PubMed ID: 37475123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
    Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
    J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?
    Osorio-de-Castro CGS; Azeredo TB; Pepe VLE; Lopes LC; Yamauti S; Godman B; Gustafsson LL
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):402-412. PubMed ID: 29117642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
    Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
    ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities.
    Govender T; Suleman F; Perumal-Pillay VA
    J Pharm Policy Pract; 2021 Dec; 14(1):105. PubMed ID: 34906236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.
    Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW
    Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
    Naicker I; Suleman F; Perumal-Pillay VA
    J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential medicines availability is still suboptimal in many countries: a scoping review.
    Mahmić-Kaknjo M; Jeličić-Kadić A; Utrobičić A; Chan K; Bero L; Marušić A
    J Clin Epidemiol; 2018 Jun; 98():41-52. PubMed ID: 29452222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of essential medicines lists: the South African case study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance.
    Perumal-Pillay VA; Suleman F
    S Afr Fam Pract (2004); 2021 Jan; 63(1):e1-e3. PubMed ID: 33567840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.